Independent Director · iTeos Therapeutics, Inc. (ITOS)

Ann D. Rhoads director compensation at iTeos Therapeutics: $346K

Fiscal year 2024 director compensation for Ann D. Rhoads at iTeos Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 24, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Ann D. Rhoads’s full pay file as a PDF — free

More than this page: up to 10 years of Ann’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Ann D. Rhoads and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

iTeos Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as iTeos Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$64,604$0$280,962$0$345,566
FY2023$64,000$0$253,523$0$317,523

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: iTeos Therapeutics, Inc. DEF 14A filed April 24, 2025, accession 0000950170-25-057666, and prior-year filings. Open the filing on EDGAR.

How this page was built: the iTeos Therapeutics, Inc. filed document, accession 0000950170-25-057666. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2025.

Get the iTeos Therapeutics Board Governance Report

$345,566 Ann D. Rhoads, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 24, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

iTeos Therapeutics pays directors a $40,000 cash retainer and $280,962 in Options.

The rest of the iTeos Therapeutics board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Aaron DavisIndependent Director$280,962
David K. LeeIndependent Director$320,072
David L. HallalIndependent Director$442,822
Jill DeSimoneIndependent Director$686,270
Michel DetheuxDirector—
Robert IannoneIndependent Director$341,264
Tim van HauwermeirenIndependent Director$331,566
Tony HoIndependent Director$332,764

The full iTeos Therapeutics compensation record

free company brief

This page is one director within iTeos Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order ITOS

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report